CYLLENE SAINTELIEN: Open Payments
NPI 1174715957 · PLYMOUTH, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$371 in 15 payments from 7 companies in 2025. Trend: 2023 $131 · 2024 $316 · 2025 $371
Food & beverage: $371
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $88 |
| ABBVIE INC. | 3 | $85 |
| Janssen Pharmaceuticals, Inc | 3 | $71 |
| Otsuka America Pharmaceutical, Inc. | 3 | $63 |
| Alkermes, Inc. | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| HARMONY BIOSCIENCES LLC | 1 | $21 |
Products named: CAPLYTA, VRAYLAR, SPRAVATO, REXULTI, ARISTADA, Sunosi, WAKIX.
Industry payments across MA — which companies pay providers there.
